tegafur has been researched along with Multiple Organ Failure in 2 studies
Multiple Organ Failure: A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sarcopenia is related to poor survival in gastric cancer patients and appears to be a significant negative prognostic factor in patients with gastric cancer who underwent curative resection." | 1.48 | Long-Term Outcomes of Gastric Cancer Patients with Preoperative Sarcopenia. ( Aoyama, T; Bando, E; Inano, T; Kawamura, T; Makuuchi, R; Tanizawa, Y; Terashima, M; Tokunaga, M; Yasui, H, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamura, T | 1 |
| Makuuchi, R | 1 |
| Tokunaga, M | 1 |
| Tanizawa, Y | 1 |
| Bando, E | 1 |
| Yasui, H | 1 |
| Aoyama, T | 1 |
| Inano, T | 1 |
| Terashima, M | 1 |
| Bosch, TM | 1 |
| Meijerman, I | 1 |
| Beijnen, JH | 1 |
| van Thiel, SW | 1 |
| Vlasveld, LT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Oral Nutritional Supplement on Nutritional Status and Clinical Outcome in Gastric Cancer Patients After Total Gastrectomy[NCT05823272] | 60 participants (Anticipated) | Interventional | 2023-05-05 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for tegafur and Multiple Organ Failure
| Article | Year |
|---|---|
Long-Term Outcomes of Gastric Cancer Patients with Preoperative Sarcopenia.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Cause of Death; Chemotherapy, Adjuvant; Dr | 2018 |
Lethal toxicity of uracil/tegafur in the treatment of sigmoid carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aryl Hydrocarbon Hydroxylases; Cytochrome P-45 | 2007 |